Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)

NCT00286559 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped echo contrast agents no longer allowed in CAD patients.

Conditions

Coronary Artery Disease

Interventions

DRUG: SonoVue
DRUG: Optison

Sponsor

University Hospital, Basel, Switzerland